RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Surgical Science Sweden Stock

Surgical Science Sweden ROE 2025

Surgical Science Sweden ROE

0.03

Ticker

SUS.ST

ISIN

SE0014428512

WKN

A2P46G

In 2025, Surgical Science Sweden's return on equity (ROE) was 0.03, a -49.37% increase from the 0.05 ROE in the previous year.

Surgical Science Sweden Aktienanalyse

What does Surgical Science Sweden do?

Surgical Science Sweden AB is a Swedish company specializing in the development and manufacturing of medical simulators for training professionals in the medical industry. The company was founded in 1999 by a team of doctors, engineers, and scientists and is headquartered in Gothenburg. Since then, the company has constantly expanded and now has several branches around the world, including in the USA, Germany, and Hong Kong. Due to its innovative products and high-quality standards, the company is globally recognized and has received numerous awards. Surgical Science Sweden AB offers a wide range of simulators for various medical disciplines, including surgery, anesthesia, obstetrics, and pediatrics. They offer both hardware and software-based solutions that allow trainees to practice complex procedures and interventions in a safe environment. The company's business model is based on the belief that simulation is crucial for the training of medical professionals to ensure the highest quality and safety for patients. By simulating realistic situations, trainees can gain valuable experience before working in the real practice. Surgical Science Sweden AB has a range of products targeting various areas of medical education. One of their most well-known simulators is the LaparoSculptor, which was specifically developed for training in minimally invasive surgery. The simulator can perform various procedures such as gallbladder and hernia operations, offering both physical and virtual options. Another product is the ObstetricSim, a simulator for obstetric training. The simulator fully simulates the conditions of a normal birth, including the stages of labor and delivery. It also includes rare complications such as shoulder dystocia and umbilical cord prolapse. Surgical Science Sweden AB has also developed simulators focusing on the training of anesthesiologists. The simulator in this area is the ANTS (Anesthesia Simulator), which trains trainees in the proper use of anesthetics, patient observation, and managing emergencies during anesthesia issues. In addition to developing hardware and software solutions, the company also focuses on continuous improvement and development of its products. Surgical Science Sweden AB works closely with leading medical specialists to ensure that the simulator meets the latest requirements and best practices. The company is also willing to rent or sell the simulators and its expertise to medical institutions, providing a broader audience with the opportunity to benefit from the technology. In conclusion, Surgical Science Sweden AB makes a significant contribution to the training of medical professionals and thereby contributes to improving patient health worldwide with its innovative and high-quality simulators. By combining the latest technology, industry expertise, and a constant focus on customer needs, the company continuously strives for excellence and innovation. Surgical Science Sweden ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROE Details

Decoding Surgical Science Sweden's Return on Equity (ROE)

Surgical Science Sweden's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing Surgical Science Sweden's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

Surgical Science Sweden's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in Surgical Science Sweden’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about Surgical Science Sweden stock

What is the ROE (Return on Equity) of Surgical Science Sweden this year?

The ROE of Surgical Science Sweden this year is 0.03 undefined.

How has the Return on Equity (ROE) of Surgical Science Sweden developed compared to the previous year?

The ROE of Surgical Science Sweden has increased by -49.37% decreased compared to the previous year.

What impact does a high ROE (Return on Equity) have on investors of Surgical Science Sweden?

A high ROE indicates that Surgical Science Sweden generates good returns on capital and is successful in monetizing its investments. This is a positive indicator for investors.

What impact does a low ROE (Return on Equity) have on investors of Surgical Science Sweden?

A low ROE can indicate that Surgical Science Sweden is having difficulties monetizing its investments successfully and can be a negative signal for investors.

How does a change in the ROE (Return on Equity) of Surgical Science Sweden affect the company?

A change in ROE (Return on Equity) of Surgical Science Sweden can be an indicator of the financial performance of the company and demonstrate how successful the company is compared to other companies in the same industry.

How to calculate the ROE (Return on Equity) of Surgical Science Sweden?

The ROE (Return on Equity) is calculated by dividing the company's profit by the total equity. The formula is: ROE = Profit / Total equity.

Which factors influence the ROE (Return on Equity) of Surgical Science Sweden?

Some factors that can influence Surgical Science Sweden's Return on Equity (ROE) include the efficiency in using equity, the profitability of the company, and the financing structure.

What strategic measures can take to improve the ROE (Return on Equity)?

To improve the Return on Equity (ROE), can take measures such as cost savings, increasing revenue, improving efficiency in the use of equity, and making changes in the financing structure. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to improve ROE.

How much dividend does Surgical Science Sweden pay?

Over the past 12 months, Surgical Science Sweden paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Surgical Science Sweden is expected to pay a dividend of 0 SEK.

What is the dividend yield of Surgical Science Sweden?

The current dividend yield of Surgical Science Sweden is .

When does Surgical Science Sweden pay dividends?

Surgical Science Sweden pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Surgical Science Sweden?

Surgical Science Sweden paid dividends every year for the past 0 years.

What is the dividend of Surgical Science Sweden?

For the upcoming 12 months, dividends amounting to 0 SEK are expected. This corresponds to a dividend yield of 0 %.

In which sector is Surgical Science Sweden located?

Surgical Science Sweden is assigned to the 'Health' sector.

Wann musste ich die Aktien von Surgical Science Sweden kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Surgical Science Sweden from 7/24/2025 amounting to 0 SEK, you needed to have the stock in your portfolio before the ex-date on 7/24/2025.

When did Surgical Science Sweden pay the last dividend?

The last dividend was paid out on 7/24/2025.

What was the dividend of Surgical Science Sweden in the year 2024?

In the year 2024, Surgical Science Sweden distributed 0 SEK as dividends.

In which currency does Surgical Science Sweden pay out the dividend?

The dividends of Surgical Science Sweden are distributed in SEK.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Surgical Science Sweden

Our stock analysis for Surgical Science Sweden Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Surgical Science Sweden Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.